Life Sciences Nova Scotia
  • About
    • COL
      • Who we are
      • What we do
    • COL
      • Why work in Nova Scotia?
    • COL
      • Contact us
  • Members
    • COL
      • Member directory
    • COL
      • Member benefits
    • COL
      • Become a member
  • Resources
    • COL
      • Member Programs
    • COL
      • News & success stories
    • COL
      • Member Job Board
  • Events
  • Podcast
Select Page

NEWS RELEASE – BioVectra Inc. excited for continued growth under experienced CDMO investor, H.I.G. Capital

by Shana Cristoferi | Nov 21, 2019 | BioVectra, News

See original news release here CHARLOTTETOWN – November 04, 2019 – Today, H.I.G. Capital, a leading global private equity investment firm with over $34 billion of equity capital under management, announced that one of its affiliates has completed the acquisition of...

NEWS RELEASE: BioVectra Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund

by Shana Cristoferi | Mar 4, 2019 | BioVectra, News

BioVectra Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund — Prime Minister Justin Trudeau visits BioVectra to announce Government of Canada investment in...

THE EMPLOYMENT JOURNEY: Summer students gain valuable experience at expanding bioscience company

by administrator | Oct 25, 2018 | BioVectra, News

Read the original article here. BioVectra Inc. is a bioscience business with three locations in Charlottetown and one in Windsor, Nova Scotia. The company, which has more than 300 employees, focuses on contract manufacturing and product development of active...

Canadian Biotech Industry Recognizes Top Performers During Global Biotech Week

by administrator | Sep 26, 2018 | BioVectra, News

BioVectra and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins

by administrator | Jul 16, 2018 | BioVectra, News

See original release here Today, BioVectra Inc., a global Contract Development and Manufacturing Organization (CDMO) with microbial fermentation and synthesis capabilities with high containment, and TUBE Biopharmaceuticals GmbH, an Austrian biotech company active in...

Mussels, potatoes, ‘Anne of Green Gables,’ and now microbial fermentation

by administrator | Jul 10, 2018 | BioVectra, News

Arriving for a visit to BioVectra, a Canadian contract development and manufacturing organization (CDMO), one is reminded that pharmaceutical services companies are an idiosyncratic lot. Most are small- to medium-sized firms whose offerings vary as widely as do their...
« Older Entries

Recent Posts

  • 3D BioFibR Appoints Dr. Michael Francis as Independent Board Member
  • Life Sciences Nova Scotia Announces the appointment of 5 New Board Members
  • BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing
  • Federal Government Prescribes $2.9M Boost For Life Sciences Sector
  • Entrevestor Live – An Awesome Display of Atlantic Canadian Innovation
No comments to show.

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow